Position in NVO
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$14,808,809
+$3,222,637 QoQ
Shares Held
308,903
-2.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#125
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $193,149,306 across 14 Drug Manufacturers - General names. NVO ranks #4 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,944 | $56,306,046 | |
| 2 | JNJ |
Johnson & Johnson
|
174,910 | $44,421,892 | |
| 3 | ABBV |
AbbVie Inc.
|
96,118 | $24,187,133 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
308,903 | $14,808,809 | |
| 5 | MRK |
Merck & Co., Inc.
|
102,060 | $13,114,710 | |
| 6 | AZN |
Astrazeneca PLC
|
56,268 | $10,669,538 | |
| 7 | AMGN |
Amgen Inc
|
26,804 | $9,706,264 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
71,841 | $9,076,391 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,808,809 | 308,903 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $11,586,172 | 315,270 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $22,481,735 | 441,858 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $23,349,914 | 420,795 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $26,089,974 | 378,006 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $7,145,514 | 102,902 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,361,230 | 97,201 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,295,982 | 86,470 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $10,835,107 | 75,908 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,944,087 | 69,658 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $8,054,720 | 77,861 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,823,228 | 75,030 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,855,009 | 36,180 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,660,856 | 23,004 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,153,963 | 23,304 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,233,804 | 22,421 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,978,969 | 26,734 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,829,998 | 25,484 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,726,032 | 15,411 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,574,371 | 16,398 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,397,367 | 16,681 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,123,689 | 16,667 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,013,663 | 14,512 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $64,708 | 932 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $914,690 | 13,969 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $754,125 | 12,527 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||